HK Stock MarketDetailed Quotes
01858 CHUNLI MEDICAL
- 11.280
- +0.020+0.18%
Not Open Apr 25 16:09 CST
4.33BMarket Cap14.12P/E (TTM)
11.640High11.180Low481.50KVolume11.240Open11.260Pre Close5.51MTurnover0.51%Turnover Ratio14.12P/E (Static)383.57MShares19.65852wk High1.36P/B1.07BFloat Cap8.32052wk Low0.34Dividend TTM95.14MShs Float62.505Historical High0.342Dividend LFY4.09%Amplitude0.768Historical Low11.440Avg Price250Lot Size3.03%Div YieldTTM3.03%Div Yield LFY
CHUNLI MEDICAL Key Stats
All
YOY
| (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Profit adjustment | ||||||||||
| Impairment and provisions: | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Revaluation surplus: | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Asset sale loss (gain): | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Depreciation and amortization: | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Operating profit before the change of operating capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Change of operating capital | ||||||||||
| Cash from business operations | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net cash from operations | 118.00%13.75M | 52.19%-38.97M | -497.38%-120.2M | -75.11%41.01M | -231.72%-76.37M | -530.17%-81.51M | -290.44%-20.12M | -36.79%164.79M | --57.98M | -19.08%18.95M |
| Cash flow from investment activities | ||||||||||
| Sale of fixed assets | ---- | ---- | ---- | 43.78%63.5K | 86.76%63.5K | 86.76%63.5K | 86.76%63.5K | -48.89%44.16K | --34K | -13.71%34K |
| Purchase of fixed assets | 39.64%-34.6M | 29.37%-19.14M | 95.17%-1.03M | 87.51%-24.9M | 68.74%-57.32M | 76.00%-27.1M | 59.67%-21.23M | -730.70%-199.41M | ---183.33M | -533.81%-112.9M |
| Acquisition of subsidiaries | ---6.99M | ---3.69M | ---9.6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | -0.83%1.53B | 65.67%1.52B | --765M | --1.41B | --1.54B | --920M | ---- | ---- | ---- | ---- |
| Cash on investment | 22.14%-1.58B | -11.99%-1.58B | -13.28%-759M | ---2.17B | ---2.03B | ---1.41B | ---670M | ---- | ---- | ---- |
| Other items in the investment business | 11.79%13.75M | 105.10%13.7M | 635.26%6.18M | 201.94%27.23M | 82.17%12.3M | 52.49%6.68M | -61.24%840.72K | 278.60%9.02M | --6.75M | --4.38M |
| Net cash from investment operations | 84.76%-81.53M | 87.47%-63.93M | 100.22%1.55M | -300.64%-762.61M | -203.02%-534.95M | -370.44%-510.36M | -1,268.38%-690.33M | -783.83%-190.35M | ---176.54M | -510.39%-108.48M |
| Net cash before financing | 88.91%-67.79M | 82.61%-102.91M | 83.30%-118.65M | -2,723.04%-721.6M | -415.61%-611.32M | -561.04%-591.87M | -1,681.32%-710.45M | -110.69%-25.56M | ---118.56M | -1,686.41%-89.54M |
| Cash flow from financing activities | ||||||||||
| Dividends paid - financing | -139.92%-120.06M | ---- | ---- | ---49.96M | ---50.04M | ---36.94M | ---- | ---- | ---- | ---- |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.08B | ---- | ---- |
| Other items of the financing business | 91.78%-722.7K | 88.93%-132.5K | ---202.69K | -313.55%-9.08M | -421.72%-8.79M | 6.34%-1.2M | ---- | ---2.2M | ---1.69M | ---1.28M |
| Net cash from financing operations | -105.30%-120.78M | 99.65%-132.5K | ---202.69K | -105.50%-59.04M | -3,391.42%-58.83M | -2,884.11%-38.13M | --0 | 9,140.95%1.07B | ---1.69M | 89.24%-1.28M |
| Effect of rate | -67.29%673.56K | 86.11%673.56K | ---- | 177.70%1.34M | 411.30%2.06M | 176.98%361.91K | -595.59%-218.02K | -29.53%-1.72M | ---661.4K | -249.59%-470.1K |
| Net Cash | 71.88%-187.89M | 83.74%-102.37M | 83.28%-118.85M | -174.48%-779.3M | -452.56%-668.09M | -589.76%-629.64M | -1,683.83%-710.67M | 363.12%1.05B | ---120.91M | -1,442.64%-91.28M |
| Begining period cash | -44.88%957.19M | -44.88%957.19M | -44.88%957.19M | 151.62%1.74B | 151.62%1.74B | 151.62%1.74B | 151.62%1.74B | 48.68%690.12M | --690.12M | 48.68%690.12M |
| Cash at the end | -28.00%769.3M | -22.77%854.83M | -18.28%838.34M | -44.88%957.19M | 87.70%1.07B | 84.83%1.11B | 57.75%1.03B | 151.62%1.74B | --569.21M | 30.68%598.83M |
| Cash balance analysis | ||||||||||
| Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Daishin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daishin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg